The TEA domain transcription factors TEAD1 and TEAD3 and WNT signaling determine HLA-G expression in human extravillous trophoblasts

B Bowen Gu (Department of Stem Cell and Regenerative Biology, Harvard University) L Leonardo M. R. Ferreira (Department of Microbiology and Immunology, Medical University of South Carolina) S Sebastian Herrera (Department of Stem Cell and Regenerative Biology, Harvard University) L Lara Brown (Division of Genetics, Department of Medicine, Brigham and Women’s Hospital Harvard Medical School) J Judy Lieberman R Richard I. Sherwood (Division of Genetics, Department of Medicine) T Torsten B. Meissner (Department of Surgery, Beth Israel Deaconess Medical Center) J Jack L. Strominger (Department of Stem Cell and Regenerative Biology, Harvard University)

Abstract

Maternal–fetal immune tolerance guarantees a successful pregnancy throughout gestation. HLA-G, a nonclassical human leukocyte antigen (HLA) molecule exclusively expressed in extravillous trophoblasts (EVT), is a crucial factor in establishing maternal–fetal immune tolerance by interacting with inhibitory receptors on various maternal immune cells residing in the uterus. While trophoblast-specific cis-regulatory elements impacting HLA-G transcription have been described, the identity of trans-acting factors controlling HLA-G expression in EVT remains poorly understood. Utilizing a genome-wide CRISPR-Cas9 knockout screen, we find that the WNT signaling pathway negatively regulates HLA-G expression in EVT. In addition, we identified two trophoblast-specific transcription factors, TEAD1 and TEAD3, required for HLA-G transcription in EVT in a Yes-associated protein-independent manner. Altogether, we systematically elucidated essential genes and pathways underlying HLA-G expression in EVT, shedding light on the mechanisms of maternal–fetal tolerance and potentially providing insights into controlling HLA-G expression beyond EVT to protect allogeneic cells from immune rejection.

Article Details

Volume / Issue Vol. 122, Issue 12
Published March 25, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (8)

B

Bowen Gu

Department of Stem Cell and Regenerative Biology, Harvard University

L

Leonardo M. R. Ferreira

Department of Microbiology and Immunology, Medical University of South Carolina

S

Sebastian Herrera

Department of Stem Cell and Regenerative Biology, Harvard University

L

Lara Brown

Division of Genetics, Department of Medicine, Brigham and Women’s Hospital Harvard Medical School

J

Judy Lieberman

R

Richard I. Sherwood

Division of Genetics, Department of Medicine

T

Torsten B. Meissner

Department of Surgery, Beth Israel Deaconess Medical Center

J

Jack L. Strominger

Department of Stem Cell and Regenerative Biology, Harvard University